Public-private partnership in action

Each year more than 14.5 thousands of Tatarstan citizens first diagnosed cancer, more than half of the cases are in the early stages. For the treatment radiation techniques are required. It is no secret that the level of modernization of the equipment in the Russian Federation is extremely low. In particular, the health care.

"Negotiations of Export Corporation with the Spanish group of companies "Eresa", which is a world leader in the provision of radiotherapy services were held. And in the early stages it was about the export of services. But when in the work involved the Ministry of Health of the Republic of Tatarstan, it was found that the interaction potential is much broader. By the end of six monthly cooperation agreed to establish a joint venture based on public-private partnerships. The volume of Spanish investments will amount to 5.6 mln. euros. It is expected that the use of new equipment of such level will work not only for the residents of Tatarstan, but also for the whole the Volga Federal District. We will be able to treat the early stages of malignant neoplasms and in fact provide longer life for people with cancer," said Taliya Minullina.

Today, December 22 was held a meeting of the President of the Republic of Tatarstan Rustam Minnikhanov with representatives of the group of companies "Eresa".

The President set a task to work out a scheme for the creation of the joint venture within a month. This project will become thse for further expansion of areas of cooperation, for example in the field of genetics.

Foe reference: Eresa Medical Group is one of the major business groups in Spain and Europe in the provision of specialized medical services using innovative technologies.

Eresa has 40 years of experience and is the leader in integrated diagnostics, genetic diagnostics, anatomical pathology and anatomic laboratories. Eresa group of companies includes 30 medical centers in 5 continents, which employs about 600 professionals. The company has advanced technology in MRI, CT, ultrasound, nuclear medicine, radiotherapy and genomic technologies.